Your browser doesn't support javascript.
loading
Kallikrein 5 Inhibition by the Lympho-Epithelial Kazal-Type Related Inhibitor Hinders Matriptase-Dependent Carcinogenesis.
da Silva, Elaine Zayas Marcelino; Fraga-Silva, Thais Fernanda de Campos; Yuan, Yao; Alves, Márcia Gaião; Publio, Gabriel Azevedo; da Fonseca, Carol Kobori; Kodama, Márcio Hideki; Vieira, Gabriel Viliod; Candido, Marina Ferreira; Innocentini, Lara Maria Alencar Ramos; Miranda, Mateus Gonçalves; da Silva, Alfredo Ribeiro; Alves-Filho, Jose Carlos; Bonato, Vania Luiza Deperon; Iglesias-Bartolome, Ramiro; Sales, Katiuchia Uzzun.
Afiliación
  • da Silva EZM; Department of Cell and Molecular Biology and Pathogenic Bioagents, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto 14049-900, SP, Brazil.
  • Fraga-Silva TFC; Basic and Applied Immunology Program, Department of Biochemistry and Immunology, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto 14049-900, SP, Brazil.
  • Yuan Y; Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • Alves MG; Department of Cell and Molecular Biology and Pathogenic Bioagents, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto 14049-900, SP, Brazil.
  • Publio GA; Departament of Pharmacology, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto 14049-900, SP, Brazil.
  • da Fonseca CK; Department of Cell and Molecular Biology and Pathogenic Bioagents, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto 14049-900, SP, Brazil.
  • Kodama MH; Department of Cell and Molecular Biology and Pathogenic Bioagents, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto 14049-900, SP, Brazil.
  • Vieira GV; Department of Cell and Molecular Biology and Pathogenic Bioagents, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto 14049-900, SP, Brazil.
  • Candido MF; Department of Cell and Molecular Biology and Pathogenic Bioagents, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto 14049-900, SP, Brazil.
  • Innocentini LMAR; Dentistry and Stomatology Division, Ophthalmology, Otolaryngology, and Head and Neck Surgery Department, Clinical Hospital of Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto 14049-900, SP, Brazil.
  • Miranda MG; Department of Cell and Molecular Biology and Pathogenic Bioagents, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto 14049-900, SP, Brazil.
  • da Silva AR; Department of Pathology and Legal Medicine, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto 14049-900, SP, Brazil.
  • Alves-Filho JC; Departament of Pharmacology, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto 14049-900, SP, Brazil.
  • Bonato VLD; Basic and Applied Immunology Program, Department of Biochemistry and Immunology, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto 14049-900, SP, Brazil.
  • Iglesias-Bartolome R; Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • Sales KU; Department of Cell and Molecular Biology and Pathogenic Bioagents, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto 14049-900, SP, Brazil.
Cancers (Basel) ; 13(17)2021 Aug 31.
Article en En | MEDLINE | ID: mdl-34503205
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Suiza